Risk variants for schizophrenia affect more than 100 genomic loci, yet cell-and tissue-specific roles underlying disease liability remain poorly characterized. We have generated for two cortical areas implicated in psychosis, the dorsolateral prefrontal cortex and anterior cingulate cortex, 157 reference maps from neuronal, neuron-depleted and bulk tissue chromatin for two histone marks associated with active promoters and enhancers, H3-trimethyl-Lys4 (H3K4me3) and H3-acetyl-Lys27 (H3K27ac). Differences between neuronal and neuron-depleted chromatin states were the major axis of variation in histone modification profiles, followed by substantial variability across subjects and cortical areas. Thousands of significant histone quantitative trait loci were identified in neuronal and neuron-depleted samples. Risk variants for schizophrenia, depressive symptoms and neuroticism were significantly over-represented in neuronal H3K4me3 and H3K27ac landscapes. Our Resource, sponsored by PsychENCODE and CommonMind, highlights the critical role of cell-type-specific signatures at regulatory and diseaseassociated noncoding sequences in the human frontal lobe.
R ecent progress in understanding the genetic basis of many psychiatric diseases has identified both rare and common variants responsible for genetic risk 1 . Integrating epigenomics data from disease-relevant cell types and tissues promises to enhance interpretation of these risk variants and the mechanisms by which they confer disease liability 2 . This includes the exploration of noncoding regulatory DNA and its epigenetic variation in mediating the effects of genetic risk variants [2] [3] [4] . Thus, the long-term goal of the PsychENCODE 5,6 and CommonMind 7 consortia is to generate a large-scale epigenomics resource for the human brain to serve as a foundation for integrative genomics in psychiatric research 6 . In this regard, nucleosomal histone modifications contribute to genome organization and function, with various histone methylation and acetylation markings, including H3K4me3 and H3K27ac, considered key regulators for active promoters and enhancers and other cis-regulatory noncoding sequences 8 . Importantly, molecular regulators for such types of open-chromatin-associated histone modifications rank as top-scoring biological pathways by genomewide association in schizophrenia and bipolar disorder 9 , further underscoring the importance of fine-mapping histone landscapes in brain. However, only a few publicly available histone datasets and resources exist for the human brain 5, 10, 11 , all of which were created from bulk tissue homogenate. These tissue-homogenate-based resources have clearly contributed to a deeper understanding of the genetic risk architecture of common psychiatric disease. However, there is evidence that, even in the context of normal cortical development and aging, vast portions of the neuronal genome show a very different histone modification landscape in comparison to those of the surrounding glia and other non-neuronal cells 12, 13 . Unfortunately, the degree to which cell-type-and region-specific epigenomic signatures mediate the influence of genetic risk factors for psychiatric disease remains largely unexplored.
Here we present the largest dataset to date of open-chromatinassociated histone modifications mapped separately in neurons versus the remaining neuron-depleted cell fraction from two higher order brain areas implicated in schizophrenia and other psychiatric diseases 14 : dorsolateral prefrontal cortex (PFC) and anterior cingulate cortex (ACC). Our publicly accessible resource, available at http://psychencode.org/ and https://www.synapse. org/#!Synapse:syn4566010, includes data, results and UCSC browser visualizations for cell-type-specific maps from N = 129 samples, complemented with another N = 28 maps from tissue ResouRce NaTuRE NEuROsCiENCE homogenate from adult control subjects without known neurological or psychiatric disease ( Supplementary Table 1 ). This epigenomics resource provides hitherto unexplored insights into cell-and region-specific histone methylation and acetylation landscapes, including sites with extraordinarily high inter-individual variability. We elucidate the influence of genetic regulation on chromatin state and identify thousands of significant histone quantitative trait loci (hQTLs). We report striking enrichments of risk variants for schizophrenia, educational attainment, neuroticism and depressive symptoms highly specific to neuronal chromatin, thereby critically confirming cell type as a key variable in the neurogenomic architecture of psychiatric disease.
Results
Samples and sequencing. Nuclei were extracted from previously frozen gray matter collected from two frontal lobe areas implicated in higher order processing serving cognition and emotion: the dorsolateral prefrontal cortex (PFC), at the superior frontal gyrus, and the anterior cingulate cortex (ACC), positioned immediately dorsoanterior to the corpus callosum ( Fig. 1a, left) . Chromatin immunoprecipitation and sequencing (ChIP-seq) with anti-H3K4me3 and anti-H3K27ac antibodies followed by 100-base-pair paired end sequencing was performed for neuronal and non-neuronal nuclei separately after NeuN neuronal marker immunotagging and fluorescence-activated sorting (Fig. 1a, right) . NeuN, broadly expressed in the vast majority of cortical excitatory and inhibitory neurons 15 , is a prototypical neuronal marker in adult human cortex 16 . We herein refer to the NeuN + fraction as neuronal and the NeuNfraction as neuron-depleted, while acknowledging that each of these two cell types is comprised of many different subpopulations 17 . Performing cell-type-specific ChIP-seq on two brain regions from each of 17 subjects (14 males and 3 females), we generated N = 129 cell-type-specific libraries (N = 63 H3K4me3; N = 66 H3K27ac), as well as N = 28 tissuehomogenate-based libraries from N = 19 additional controls (N = 11 H3K4me3, 4 female, 7 male; N = 17 H3K27ac, 8 female, 9 male) passing ENCODE quality controls (> 10 million uniquely mapped reads, normalized strand coefficient (NSC) > 1 and PCR bottleneck coefficient > 0.8; Supplementary Fig. 1 and Supplementary Table 2 ).
For downstream analysis, we consolidated multiple ChIP-seq datasets by cell type for each brain region and histone mark as (i) H3K4me3 PFC neuronal, (ii) H3K4me3 PFC neuron-depleted, (iii) H3K4me3 ACC neuronal, (iv) H3K4me3 ACC neuron-depleted, (v) H3K27ac PFC neuronal, (vi) H3K27ac PFC neuron-depleted, (vii) H3K27ac ACC neuronal and (viii) H3K27ac ACC neuron-depleted. Tissue homogenate samples for each histone mark were consolidated as (ix) H3K4me3 PFC HBCC homogenate and (x) H3K27ac PFC HBCC homogenate. (Although all our samples were acquired through the Human Brain Collection Core (HBCC) brain bank, the "HBCC" identifier was used for the homogenate samples alone in order to distinguish them from the Roadmap Epigenomics Project tissue homogenates in our subsequent analysis.) Supplementary Table 3 shows the list of samples in each of the ten consolidated datasets (see Methods for a detailed description of the consolidation steps). The average number of uniquely mapped and nonredundant reads for the consolidated datasets by cell type and brain region ranged from 13 to 41 million for H3K4me3 and 23 to 125 million for H3K27ac, reflecting that H3K27ac samples were sequenced at twice the coverage depth due to their larger width ( Supplementary  Fig. 1a ). The subsequent steps of peak calling, read quantification of each peak, exploration of technical and biological covariates, differential modification analysis and functional annotation of peak sets (see Supplementary Fig. 2 for workflow diagram) were performed on each consolidated dataset. Across all individuals and both histone marks, ~50-70% of consolidated peaks in the cell-type-specific data and ~20-40% in the tissue homogenate data had read coverage of at least 1 count per million (CPM) ( Supplementary Fig. 3 ).
To evaluate the specificity of our histone-modification maps, we compared the peak coordinates to published H3K4me3 and H3K27ac maps from the Roadmap Epigenomics Project (REP) covering 111 tissues 5 . The maximum similarity (estimated based on Jaccard's J) was found when our consolidated subset was compared to the REP brain tissues, while overlap with non-neural and peripheral REP tissues was lower ( Supplementary Fig. 4 and Supplementary Table 4 ). For both brain regions and epigenetic marks, our neuron-depleted samples, which overwhelmingly comprise non-neuronal cells, had a higher similarity with REP brain samples than neuronal samples. Likewise, our NeuN -H3K27ac landscapes displayed a higher similarity with H3K27ac and also histone H3 acetyl-Lys9 (H3K9ac) landscapes collected from bulk cortex tissue (homogenate) from independent brain cohorts 10, 11 . These observations, taken together, likely reflect the fact that the majority of cells residing in cortical gray matter are indeed non-neuronal 18 .
Genome-wide analysis of H3K4me3 and H3K27ac peaks reveal cell type specificity. The cell-type-specific peak sets (peaks called on consolidated datasets i-viii above) varied by the fraction of the genome covered by peak regions, as well as by the degree of overlap with other subsets. As expected, the 61,000-95,000 narrow H3K4me3 peaks (range reflecting different cell types and cortical areas) covered a much smaller fraction of the genome than the 91,000-116,000 broader H3K27ac peaks (Supplementary Table 5 ). For example, in PFC neurons, H3K4me3 peaks covered 82 Mb (2.8%) of the genome, while H3K27ac covered 595 Mb (19.8%) in the same subset ( Fig. 1b-e ). Only minimal differences in the percentage of genomic coverage by H3K4me3 peaks (2.7-2.9%) was observed across cell types, whereas H3K27ac showed much higher genomic coverage for neuronal (19.8-20 .4%) than neuron-depleted (15.5-16.9%) chromatin ( Fig. 1c ).
Principal component analysis revealed distinct clusters of neuronal, neuron-depleted (non-neuronal) and homogenate samples for both histone marks ( Fig. 1f,g and Supplementary Fig. 5a ); however, samples from the PFC and ACC clustered together ( Supplementary  Fig. 5b ). This indicates a relatively high degree of epigenetic difference between neuronal and non-neuronal chromatin compared to a minimal difference between cortical areas. In contrast, chromatin from our PFC tissue homogenate samples and additional homogenate brain tissue from other sources 5, 10 fell between that of the FACSsorted cells along the first principal component ( Fig. 1f,g) . Notably, the HBCC homogenate PFC samples were much more similar to the non-neuronal component, and the fraction of NeuNnuclei in our tissue homogenates comprised, on average, 60-70% of the total population (Supplementary Fig. 6 and Supplementary Table 6 ), which is consistent with the fact that non-neuronal cells outnumber neurons by 1.6-2:1 in the human frontal lobe 18 . To further explore this similarity of PFC homogenate with non-neuronal cells, we quantified and analyzed the non-overlapping regions of PFC neuronal, PFC neuron-depleted and PFC HBCC homogenate peak sets. PFC neuronal chromatin included vast amounts of H3K27ac (369 Mb) and H3K4me3 (46 Mb) peak sequences not shared with either neuron-depleted or tissue homogenate, while only 245 Mb (H3K27ac) and 15 Mb (H3K4me3) of peak sequences were unique to non-neuronal chromatin and not shared with tissue chromatin extracts or neurons ( Fig. 2a ). Taken together, these characteristics illustrate a crucial advantage of cell-specific data over homogenate data. Functional enrichment of genes in close proximity to these non-overlapping modified peak regions using GREAT 19 indicated distinct biological functions by cell type ( Fig. 2b and Supplementary  Table 7a -f). Neuron-specific H3K4me3 and H3K27ac peaks were enriched for ion channels, neurotransmitter signaling and synaptic genes, while genome regions marked in neuron-depleted and tissue homogenate peak sets showed enrichment for broader, less defined categories ( Fig. 2b) . 
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While this analysis has described large-scale trends, cell specificity of histone modification is readily visualized at the gene level.
As representative examples, we consider CAMK2A and OLIG1, which are neuron-and non-neuron-specific genes, respectively (see Supplementary Fig. 7 ).
Collectively, our findings affirm that the neuronal epigenomic landscape is distinct from both non-neuronal and tissue homogenate landscapes. Although our findings indicate that chromatin maps from homogenate may omit critical neuron-specific epigenomic signatures, they do, however, provide a better representation of non-neuronal chromatin. Indeed, analysis of published brain hQTLs from H3K27ac profiles in cortical homogenate 10 showed modest enrichment for overlap with our NeuN -H3K27ac peaks, but a depletion for overlap with our NeuN + H3K27ac peaks ( Supplementary Fig. 8 ). This enrichment was highly specific, as these hQTLs were depleted for overlap with H3K4me4 peaks. Moreover, analysis of another type of H3-acetyl mark, H3K9ac, from brain tissue homogenate 11 showed only depletion for overlap with the two marks from neuronal and neuron-depleted chromatin in this study ( Supplementary Fig. 8 ).
Neuronal histone modification landscapes show strong enrichment of schizophrenia GWAS loci.
Owing to the distinct histone modification landscapes between neuronal and non-neuronal cells in the frontal lobe, we wanted to better understand the role of celland region-specific epigenomic regulation associated with various psychiatric and nonpsychiatric traits. To this end, we used the linkage disequilibrium (LD)-score partitioned heritability method 20 to examine the enrichment of common genetic variants identified by genome-wide association studies (GWAS) within genomic regions with cell-type-specific histone modifications. Altogether, 18 different types of brain-and non-brain-related diseases and conditions were included in these analyses (Fig. 3 ).
The strongest enrichment was found for schizophrenia-associated loci; weaker (but nonetheless significant) enrichments were found for the genetic architectures associated with education years, intelligence, neuroticism, depressive symptoms, body mass index, chronotype and sleep duration ( Supplementary Table 8a ,b). Strikingly, each of these enrichments was almost exclusively limited to the neuronal histone modification landscapes of the PFC and ACC, suggesting that the aforementioned GWAS datasets link disease-associated vulnerabilities ResouRce NaTuRE NEuROsCiENCE specifically to neurons. Indeed, the neuron-specific enrichment for sequences implicated in schizophrenia risk were consistently more significant than the comparatively weaker enrichment for these risk sequences in the histone modification maps from brain tissue homogenate herein, as well as in published H3K27ac 10 and H3K9ac 11 maps from brain tissue homogenate ( Fig. 3 and Supplementary Fig. 9 ). For non-brain-related traits such as height, coronary artery disease, Crohn's disease and ulcerative colitis, we observed little enrichment for peaks from either neuronal and neuron-depleted chromatin. Furthermore, the strongest enrichment of brain related traits was identified in the non-overlapping peak regions of PFC neurons compared with the PFC HBCC homogenate peak sets, which further corroborates the association of GWAS loci of neuropsychiatric diseases with neuronspecific chromatin regions (Supplementary Fig. 9 and Supplementary  Table 8c ,d). Finally, LD-score regression coefficients 20 from the enrichment analysis of schizophrenia were significantly larger in neuronal as compared to neuron-depleted chromatin, and this effect was consistently observed for both histone marks in the two cortical regions, ACC and PFC ( Supplementary Fig. 10 ). However, neither neuronal nor neuron-depleted PFC and ACC chromatin showed any significant overlap with Alzheimer's disease-associated variants, consistent with the hypothesis that Alzheimer's disease risk variants are enriched for regulatory sequences within cells of myeloid origin [21] [22] [23] Decomposing quantitative variation in histone modification into multiple components. Quantitative epigenetic variation could be attributed to biological variation across cell types, subjects, brain regions and sexes. To quantify the percentage of variation in histone modification in each peak region that is attributable to each of these four variables plus residual variation, we fit a linear mixed model using variancePartition 24 (Fig. 4 ). Since variance percentages sum to 100%, these values can be easily compared across variables, peak regions and histone marks. The variance percentages are easily interpretable visually: a peak region with high variation across cell types shows distinct levels of histone modification in neuronal versus neuron-depleted chromatin (Fig. 4a ). The genome-wide trend across all peak regions for each mark indicates that cell type was the strongest source of variation in histone modification, followed by subject ( Fig. 4b,c ). In contrast, variation across brain regions was very limited. Finally, as expected, variation across sexes was minimal genome-wide while exerting a strong effect on genes linked to chromosomes X and Y. To further clarify the extent to which epigenomic differences between male and female frontal cortex are driven by histone peaks located on the sex chromosomes, we conducted principal component analysis of our 83 H3K27ac samples (11 female, 72 male), including cell-type-specific and tissue homogenate datasets. Inclusion of regions on chromosomes X and Y indeed resulted in strong sex-specific clustering on the fourth principal component while male and female brains completely intermixed when the analyses with repeated under exclusion of histone-tagged sequences specific to the X and Y chromosomes ( Supplementary Fig. 11 ). Finally, to interpret the peak regions with the highest variation across subjects, we computed the overlap of peak regions from the current dataset with regions that have genome-wide significant 
Fig. 3 | Enrichment of heritability for brain-and non-brain-related phenotypes within cell-and tissue-specific histone peaks. a,b,
Using LD-score regression to partitioned heritability, we tested whether the genetic variants contributing to 18 brain-and non-brain-related phenotypes were enriched for H3K4me3 (a) and H3K27ac (b). In a, heritability enrichment analysis was performed on multiple sets of genome regions that are visualized in three blocks. (i) Regions marked in blue and gold show enrichment values of PFC neuronal (63,642 (105,075) peaks), ACC neuronal (61,043 (116,714) peaks), PFC neuron-depleted (95,501 (91,037) peaks) and ACC neuron-depleted (87,292 (101,885) peaks) from consolidated H3K4me3 (H3K27ac) datasets.
(ii) Regions marked in black show enrichment value of PFC tissue from our dataset (158,345 (183,885) peaks), REP PFC tissue (75,912 (317,582) peaks), and REP ACC tissue (79,844 (260,288) peaks) for H3K4me3 (H3K27ac) marks. (iii) Regions showing statistically significant differential histone modification between either the two cell types or two brain regions. Results for peaks that show increased histone modification in neurons (28,838 (59,588) peaks) or non-neurons (31,790 (58,120) peaks) from H3K4me3 (H3K27ac) marks are indicated in blue and gold, respectively. Results for peaks that show increased histone modification in PFC (696 (10,665) peaks) or ACC (508 (10,797) peaks) from H3K4me3 (H3K27ac) are indicated in purple and green, respectively. Layout in b is the same as in a except that enrichment of 56,503 peaks from PFC tissue from Sun et al. 10 
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hQTLs identified in lymphoblastoid cell lines and human brains for the H3K4me3 25 and H3K27ac 10 epigenetic marks, respectively. Peak regions with high variation across subjects were indeed enriched for regions that are hQTLs in lymphoblastoid cell lines and human brains for their respective histone mark ( Fig. 4d,e ). This is consistent with variation in histone modification across subjects being driven at least in part by genetic regulatory variation 10, 25, 26 . Importantly, this enrichment is limited to loci subject to epigenomic regulation that are common between neuronal and neuron-depleted chromatin (this study) and tissue extract and lymphoblast lines from previous studies 10, 25 .
Genetic regulation of histone modification in neuronal and neuron-depleted fractions. To examine whether there is cell-typespecific genetic regulation of histone modifications (as has been observed previously for gene expression 6, 27 ), we applied RASQUAL (robust allele-specific quantitation and quality control), a QTL approach integrating allele-specific and between-subject differences 28 . Each of the four neuronal, neuron-depleted and bulk tissue chromatin preparations indeed harbored thousands of hQTLs, ranging from 6,695 to 8,042 for H3K27ac and 1,565 to 3,517 for H3K4me3 at a false discovery rate (FDR) < 0.05, depending on chromatin fraction ( Supplementary Fig. 12 and Supplementary Table 9 ). Of note, H3K27ac-tagged chromatin showed unexpectedly strong enrichment for Gene Ontology GREAT biological processes such as neurofilament organization, regulation of synaptic plasticity, associative learning, catecholamine-dependent signaling and various other pathways highly relevant to the neurobiology of schizophrenia and other common psychiatric disease ( Supplementary Fig. 13 ).
Since hQTLs calling was slightly underpowered as a result of the small sample size (n = 36), we took the simple approach of comparing our cell-specific and bulk tissue hQTLs with data from GWAS for schizophrenia 29 . We took all associations with P < 5 × 10 −8 that are in high LD (r 2 > 0.8) with the lead single-nucleotide polymorphism (SNP) and evaluated their overlap with our hQTLs. Comparisons across bulk tissue, neuronal and neuron-depleted chromatin revealed strong cell-type-specific effects for many of these riskassociated loci. For example, H3K4me3 peaks near MIR137 showed stronger hQTLs in neuronal samples than neuron-depleted and bulk tissue samples with localization of lead SNP rs1702294. H3K27ac peaks showed even stronger cell-specific hQTL signal near the voltage-gated calcium channel CACNA1C in neuronal samples, whereas peaks for both histone marks near FURIN showed a single hQTL only in neuron-depleted samples ( Fig. 5, Supplementary Fig. 12 and Supplementary Table 10 ).
Epigenomic variation between ACC and PFC.
Cell type was the major source of quantitative variation in histone modification, with 55,628 H3K4me3 and 117,708 H3K27ac peak regions epigenetically different across cell types at FDR 5% ( Fig. 6a and Supplementary Fig. 14a ). Unsurprisingly, for each histone mark, functional enrichment by gene categories was highly specific for cell type (Fig. 6b ). However, differences in histone modification between ACC and PFC were much smaller because of the similarity between the brain regions. Differential histone modification analysis between brain regions in neuronal cells identified 508 H3K4me3 and 10,797 H3K27ac peaks with increased modification in ACC, as well as 696 H3K4me3 and 10,665 H3K27ac peaks in PFC ( Supplementary Figs. 14b and 15a -c and Supplementary Tables 11 and 12 ). Notably, there was minimal region-specific signal in neuron-depleted chromatin, with only 27 H3K4me3 and 18 H3K27ac peaks with increased modification in ACC and none in PFC ( Supplementary Fig. 15d ). These results indicate dramatically higher regional specificity for the population of neurons compared to their surrounding non-neuronal cells in the frontal lobe. It remains to be determined whether the differential histone acetylation landscapes in PFC vs. ACC neurons are reflective of differences in neurocognitive function between these cortical areas. For example, there is robust ACC activation with regard to reward processing, pain, affect and emotion 30 . In contrast, dorsolateral PFC is frequently implicated in the regulation of goal-directed behavior, including working memory and executive functions 31 . We note that multiple peak regions that were differentially modified between PFC and ACC neurons are proximal to neuropsychiatric risk genes ( Supplementary Tables 13 and 14) . These include the forkhead transcription factor FOXP1, which functions synergistically with a related molecule, FOXP2, to regulate cognition and No. of cell-type-specific peaks (FDR < 5%)
No. of peaks in consensus peak set NeuN + -specific peaks NeuN --specific peaks ResouRce NaTuRE NEuROsCiENCE speech 32 ; the exocytosis regulator CADPS2, which is essential for axonal release of brain-derived nerve growth factor (BDNF) 33 ; and the GRIK4 kainate receptor, relevant for a broad range of disorders on the autism, mood and psychosis spectrum 34, 35 .
Transcriptional signatures of promoter-bound histone methylation and acetylation. While histone peaks from neuronal and neuron-depleted chromatin were bound to promoters, introns and intergenic elements ( Supplementary Fig. 16 ), annotation of the H3K4me3 and H3K27ac peak sequences in the consolidated subsets revealed that a large majority of sequences (70-79% of H3K4me3tagged and 57-68% of H3K27ac-tagged) were bound to promoters within 5 kb of annotated transcription start sites (TSS). We therefore examined whether levels of H3K4me3 and H3K27ac modification are associated with gene expression magnitude in an independent set of postmortem brain samples from dorsolateral PFC from the CommonMind Consortium 7 . To this end, we calculated the number of ChIP-seq reads aligned within 15 kb of the annotated TSS of genes in five gene sets grouped by expression magnitude. As expected from findings in peripheral cells and tissues 8 , both H3K4me3 and H3K27ac ChIP-seq reads were enriched around the TSS of genes with high levels of expression compared to genes with low levels of expression ( Supplementary Fig. 17 ).
In our final analyses, we examined the association of the neuronal, neuron-depleted and homogenate chromatin landscape with gene expression magnitudes in multiple subtypes of neurons and glia recently identified by massively parallel profiling of single brain nuclei 17 . There were indeed strong cell-type-specific chromatin effects, with neuron-depleted chromatin showing strong enrichment for oligodendrocyte-and astrocyte-specific transcripts while conversely neuronal chromatin profiles were more strongly associated with transcripts of the various types of neurons as compared to glia (Fig. 7) . In contrast, these enrichments showed no cell type specificity for chromatin fractions prepared from tissue homogenate (Fig. 7) . Not limiting our analyses to cell types, we examined the association of neuronal, neuron-depleted and homogenate chromatin with differentially expressed transcripts in multiple cohorts of subjects diagnosed with autism, bipolar disorder or schizophrenia 36 . Both cell-type and homogenate chromatin fractions showed moderate levels of enrichment with these diseaserelated gene sets (Fig. 7) .
Discussion
Interpreting the functional consequences of recently identified genetic variants contributing to the risk of neuropsychiatric disease requires a deeper understanding of the epigenomic context of these variants in brain and other tissues 2-4,6,10,11 . We built a dataset of cell-type-specific reference maps for NeuN + neuronal and NeuN -(overwhelmingly non-neuronal) histone modification landscapes for H3K4me3 and H3K27ac, which are typically associated with active promoter and enhancer regions, respectively. Notably, nonneuronal chromatin showed a high degree of concordance with epigenomic landscapes of cortical homogenates from multiple sources. In contrast, histone methylation and acetylation landscapes from ACC and PFC neurons showed considerable 'epigenomic distance' from neuron-depleted and tissue homogenate samples (Fig. 1f,g and Supplementary Fig. 5a ), suggesting they are likely a poor surrogate for neuron-specific alterations in the context of cognitive function and neurological disease. Given that the differences between neuronal and non-neuronal H3K4me3 and H3K27ac landscapes are the major axis of epigenomic variation (Fig. 4 ), it will be essential for future studies to pursue more sample fractionation by cell type in order to capture the estimated 16 neuronal populations defined by single-cell RNA sequencing in human cerebral cortex 37 , as well as potentially similar degrees of heterogeneity in glia, as recently reported for mouse brain 38 . Such a higher resolution approach is expected to reveal vast numbers of genomic loci with an epigenomic signature unique to a specific type of neuron or glia, and provide deeper insight into the interrelation of transcriptome and histone modification landscapes. We also note the unexpectedly large quantitative H3K27ac differences between cell types, with a much larger genome coverage (20%) in neuronal chromatin decorated by histone acetylation versus only 15-16% genome coverage in neuron-depleted chromatin. The extended H3K27ac coverage broadly included intronic and intergenic sequences, in addition to many promoter-bound peaks ( Supplementary Fig. 16 ). While the functional implications of the extended H3K27ac peak coverage in the neuronal genome remains to be explored, we note 36 . Enrichments were quantified for cell-specific datasets PFC and ACC neuronal (blue) and PFC and ACC neuron-depleted (gold), and for PFC tissue (homogenate) including HBCC and REP 5 . CMC, CommonMind Consortium; DG, dentate gyrus.
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that drugs interfering with the regulation of histone acetylation, including histone deacetylase inhibitors and suppressors of histone acetylation reader proteins, show a surprisingly broad therapeutic profile, improving cognition and neuronal function in a wide range of neuropsychiatric disease models [39] [40] [41] . Furthermore, consistent with previous gene expression profiles in adult frontal cortex 42 , the transcriptional histone marks of the present study, H3K4me3 and H3K27ac, showed few sex-specific histone methylation and acetylation differences in the autosomal genome ( Supplementary Fig. 11 ). However, previous DNA methylation profiling in cortical tissue homogenate from aged brains revealed sex-specific effects for approximately 10% of age-sensitive methyl-CpG marks 43 . At present, it is not known whether sex-specific regulation of histone modifications is increased in the aged brain.
One primary goal of the PsychENCODE Consortium is to explore regulatory noncoding DNA associated within the genetic risk architectures of common neuropsychiatric disorders 6 . Using LD-score regression to partition heritability 20 , we found strong, specific enrichments for schizophrenia and somewhat weaker association with depression, neuroticism and education attainment in both H3K4me3 and H3K27ac peaks (Fig. 3 ). This effect was primarily if not exclusively driven by neuronal chromatin ( Fig. 3 and Supplementary Figs. 9 and 10), with minimal or no contribution from neuron-depleted chromatin. Intriguingly, the strongest association with brain-region-specific peaks identifies risk variants for schizophrenia and educational attainment specifically in PFC neurons, consistent with the key role of the PFC in executive function. Taken together, these findings underscore the importance of epigenomic fine mapping with maximal region-and cell-type-specific resolution for the human brain in order to link the genetic risk architectures of neuropsychiatric disorders to selected cell populations or neural circuits.
Our cell-type-specific reference maps, accessible through the PsychENCODE Knowledge Portal and UCSC browser on Synapse (https://www.synapse.org/#!Synapse:syn4566010), are a resource that will empower future studies exploring the epigenetic foundations of cell-type-specific genome organization and function in human brain, with important implications for the neurobiology of common psychiatric disease.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-018-0187-0.
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ResouRce NaTuRE NEuROsCiENCE Methods Brains. All tissue donors of the present study were from the Human Brain Collection Core (HBCC) at the National Institutes of Health. None of the brains were affected by known neurological or psychiatric disease. All brains had undergone a detailed neuropathological exam (including Bielschowsky stain) and were considered normal by histopathology. Demographics of the brain cohort and toxicology and neuropathology reports are summarized in Supplementary Table  1 . Sample size: no statistical methods were used to predetermine sample sizes, but our sample sizes exceeded those reported in previous publications focused on celltype-specific histone profiling in human brain 12, 13, 44 by several-fold.
Antibodies, ChIP-seq library preparation and sequencing. Nuclei were extracted from approximately 300-mg aliquots of frozen frontal (dorsolateral prefrontal and anterior cingulate gyrus) cortex tissue and immunotagged with an anti-NeuN-Alexa488 antibody (cat. no. MAB377X, EMD Millipore) that robustly stains human cortical neuron nuclei 44,45 for subsequent fluorescence-activated nuclear sorting. Next, chromatin of sorted nuclei was digested with micrococcal nuclease and subsequently pulled down with anti-histone antibodies, followed by library preparation and sequencing. Two histone antibodies, anti-H3K4me3 (cat. no. 9751BC, lot no. 7; Cell Signaling, Danvers, MA) and anti-H3K27ac (cat. no. 39133, lot no. 01613007; Active Motif, Carlsbad, CA) were used for immunoprecipitation. Antibody specificity was tested using peptide binding assays and immunoblotting of nuclear extracts from human postmortem cortical tissue. A commercially available histone H3 peptide array (cat. no. 16-667; Millipore) containing 46 peptides representing 46 different histone H3 posttranslational modifications was used as previously described 44 . All procedures were performed as described in the recent PsychENCODE methods paper, providing a detailed description of the protocol 44 . For each cell-type-specific ChIP assay, a minimum of 400,000 sorted neuronal (NeuN + ) or neuron-depleted non-neuronal (NeuN -) nuclei was required as starting material. ChIP-PCR was conducted for selected gene promoters to validate cell-type-specific peak profiles ( Supplementary Fig. 18 and refs.44, 45). Furthermore, post-FACS quality controls for nuclei included visual inspection under the microscope as described 44 . Notably, due to our stringent FACS gating criteria maximizing specificity, not sensitivity ( Supplementary Fig.  19 ), 100% of sorted nuclei in the neuronal fraction showed green fluorescence, confirming NeuN + status, while 100% of sorted nuclei in the non-neuronal fraction showed only blue DAPI stain, confirming NeuNstatus. For the PFC samples, we collected (mean ± s.d.) NeuN + 667,675 ± 196,847 and NeuN -611,025 ± 203,172 nuclei. For the ACC samples, we collected NeuN + 490,585 ± 184,358 and NeuN -653,743 ± 389,284 nuclei.
Additional ChIP-seq studies were conducted with homogenized dorsolateral PFC as input. To this end, frozen human postmortem brain tissue (approximately 20-200 mg) was homogenized in lysis buffer and the total nuclei were purified. The nuclei were resuspended in 300 μ L of Dounce buffer and treated with 2 μ L of micrococcal nuclease (0.2 U/μ L) for 5 min at 28 °C, followed by 30 μ L of 500 mM of EDTA to stop the reaction. After this initial procedure for nuclear preparation and digestion, the sample was processed in the same manner as described for the FACS-sorted nuclear samples.
Randomization and blinding.
To avoid batch effects and other confounds, samples underwent repeated rounds of randomization, including (i) chromatin immunoprecipitation procedures and (ii) library preparation. Blinding was not relevant to this study; analysts were aware of data generation, processing and donor metadata.
ChIP-seq alignment. Sequenced cell-specific and homogenate ChIP-seq FASTQ files were aligned to the Hg19 (Feb 2009, GRCh37) human genome using the Burrows-Wheeler Aligner (BWA-0.7.8-r455) method with default settings 46 . The output files were exported as BAM files.
Filtering and quality control. PCR duplicates in aligned BAM files were removed using the Picard 2.2.4 tool 47 . After filtering out duplicates, all BAM files were preprocessed to remove unmapped reads and any interchromosomal read pairs of length > 10 kb. The mapped reads were subsampled to the median number of paired-end reads of each dataset: H3K4me3, 13 M; H3K27ac, 23 M ( Supplementary  Fig. 1 ). Any samples after removing duplicates with sequencing depth < 10 M (from ENCODE 48 ) were flagged in this study. These uniformly subsampled files were used for further downstream analysis.
Experimental design and statistical analyses.
For a general overview of the bioinformatic analyses, see Supplementary Fig. 2 . To determine the best peak calling method, we used the P value from irreproducible discovery rate (IDR) analysis, where the input was peaks called using the MACS2, PeakSeq and SPP methods. To identify differentially modified histone peaks across cell types and brain regions, we applied a quasi-likelihood negative binomial generalized loglinear model on the normalized CPM matrix. For multiple-testing correction of identified differential peaks, we used the Benjamini-Hochberg method on the P values to control false discovery rate. For pathway enrichment analysis of differentially modified peaks, we used P values from the hypergeometric test computed by GREAT and did multiple-testing correction using the Bonferroni correction method. To test overlap of identified peaks with disease-and traitassociated genetic variants, we used the LDSR method, which take P values of peak regions as an input. See below for additional details on statistical methods.
Variant calling. Variants were called from BAM files using GATK 3.5-0 49 to produce gVCF files. Variant concordance analysis was performed to identify any mislabeling. Variants on chr22 were merged using GATK's CombineVCFs functionality. Variant concordance between all pairs of samples was evaluated with bcftools v1.3 50 . Two mislabeled samples were identified and were relabeled appropriately for all downstream analyses.
Comparison of peak calling methods. For each histone mark, we consolidated BAMs across all individuals for the PFC neuronal set and subsampled three files. Our approach to determine best peak calling method was to derive the irreproducible discovery rate (IDR) 51 after calling peaks using MACS (v.2.1.0) 52 , SPP (v.1.13) 53 and PeakSeq 54 methods. Afterward, the method that gave the maximum number of overlapping regions between subsamples at 5% IDR was used for peak calling on the full dataset. We found that MACS2 was the best peak caller method, with the maximum number of peak regions at 5% IDR for both marks ( Supplementary Fig. 1d ). ENCODE uses IDR on technical replicates of samples to determine the reproducibility of peaks 51 while we have used it globally on our dataset. We applied the following parameters in MACS2: SE, SE no model, PE, PE no model and P = 0.01, 0.1, 0.5; SPP: FDR 0.01, 0.05, 0.99, background model = simulated, minimum interpeak distance = 150 and PeakSeq: target FDR = 0.01, 0.05, 0.99.
Consolidation of datasets.
For cell-specific datasets, we consolidated uniformly processed BAMs by cell type for each brain region. For example, H3K4me3modified ChIP-seq BAMs from neuronal cells from PFC brain region for all individuals (n = 17) were consolidated as the H3K4me3 PFC neuronal dataset. Consolidating the BAMs by cell type for each brain region produced eight large BAM files for both marks: (i) H3K4me3 PFC neuronal, (ii) H3K4me3 PFC neurondepleted, (iii) H3K4me3 ACC neuronal, (iv) H3K4me3 ACC neuron-depleted, (v) H3K27ac PFC neuronal, (vi) H3K27ac PFC neuron-depleted, (vii) H3K27ac ACC neuronal and (viii) H3K27ac ACC neuron-depleted.
ChIP-seq BAMs for homogenate were generated from one brain region, and therefore all individuals BAMs were consolidated into two large BAM files for both marks as (i) H3K4me3 PFC HBCC homogenate and (ii) H3K27ac PFC HBCC homogenate. Similarly, input samples were consolidated separately for cell-specific and homogenate datasets. For details of sets of individual files contributing to the consolidated dataset, see Supplementary Table 3 . We used these cell-specific (n = 8) and homogenate (n = 2) consolidated BAMs for further downstream analysis.
Peak calling. Narrow peak regions were called for H3K4me3 histone mark datasets on each of the consolidated cell-specific and homogenate BAMs-(i) H3K4me3 PFC neuronal, (ii) H3K4me3 PFC neuron-depleted, (iii) H3K4me3 ACC neuronal, (iv) H3K4me3 ACC neuron-depleted and (v) H3K4me3 PFC HBCC homogenate-with Poisson P = 0.01 and with --keep-dup all --nomodel --extsize = fragment length. Broad peak regions were called for H3K27ac histone mark datasets on each of the consolidated BAMs-(vi) H3K27ac PFC neuronal, (vii) H3K27ac PFC neuron-depleted, (viii) H3K27ac ACC neuronal, (ix) H3K27ac ACC neuron-depleted and (x) H3K27ac PFC HBCC homogenate-using the same parameters. The consolidated cell-type and homogenate input control samples were used as control inputs for peak calling on cell-specific and homogenate datasets, respectively.
All called peaks were filtered from blacklisted 48 region peaks and -log 10 (P) > 3.05 (P value obtained from IDR analysis) for downstream analysis. For each mark, the coordinates for peaks for each set-PFC neuronal, PFC neuron-depleted, ACC neuronal, ACC neuron-depleted-used in this study are given for cell-specific H3K4me3 = syn11306591, homogenate H3K4me3 = syn11306589, cell-specific H3K27ac = syn9998643 and homogenate H3K27ac = syn11485660. Before calling peaks using MACS2, we first ran SPP to find the fragment length using maximum strand cross correlation ( Supplementary Fig. 1b and Supplementary Fig. 2 ). For QC parameters (NSC, RSC, PBC and number of mapped reads) of uniformly reprocessed and consolidated ChIP-seq sets, we used phantompeakqualtools 53 . The NSC of all samples used in this study was above a threshold of 1.1 ( Supplementary  Fig. 1c ). We provide summarized QC parameters of individual files (Supplementary Table 2 ) and consolidated (Supplementary Table 5 ) datasets.
Functional enrichment of non-overlapping cell-and tissue-specific histone peaks.
To interpret the specificity of cell-type and homogenate data, we identified their respective unique or non-overlapping peak regions. Non-overlapping regions in a dataset are defined as all genomic regions except the ones that have at least 50% overlap with the dataset they are compared with. We examined the biological function of nearby genes for these non-overlapping peak regions using Genomic Regions Enrichment of Annotations Tool (GREAT) 19 . The settings for GREAT Gene set enrichment analysis based on single-cell RNA-seq. We next examined the difference between the ChIP-seq signal in cell-specific and homogenate datasets by measuring the enrichment of gene sets identified in neuronal and neuron-depleted chromatin subtypes by massively parallel profiling of single brain nuclei 17 . For neuronal subtypes we used identified gene sets for excitatory neurons (n = 24), pyramidal neuron from CA1 (n = 132), pyramidal neurons from CA2 (n = 111), pyramidal neurons from CA3 (n = 50), GABAergic interneurons (n = 145) and granule cells from the DG (n = 163), and for non-neuronal subtypes we used identified genes sets for radial glia (n = 10), myelin (n = 16), oligodendrocytes (n = 120), astrocytes (n = 155) and oligoprogenitor cells (n = 42). nsgplot v2.61 55 was used to quantify ChIP-seq reads enrichment of seven datasets for both marks-(i) PFC neuronal, (ii) PFC neuron-depleted, (iii) ACC neuronal, (iv) ACC neuron-depleted, (v) PFC HBCC homogenate, (vi) PFC REP homogenate and (vii) ACC REP homogenate-for the abovementioned neuronal and non-neuronal gene sets as a function of 15 kb distance upstream and downstream from the TSS of each gene. We calculated the magnitude of area under these ChIP-seq reads enrichment curve to examine the difference between the enrichment of cell-specific and homogenate datasets for neuronal and nonneuronal subtypes.
In addition to these gene sets, we measured the enrichment of ChIP-seq reads for neuropsychiatric disease signatures as well. We curated these gene sets for (i) CMC schizophrenia (n = 693) based on RNA-seq differential gene expression between cases and controls from PFC region from 690 individuals (P ≤ 0.05) and for (ii) schizophrenia (n = 884), (iii) bipolar disorder (n = 179), (iv) major depressive disorder (n = 25) and (v) autism spectrum disorder (n = 933) based on differential gene expression cerebral cortex region from microarray studied done on 715 individuals (P ≤ 0.05 and log 2 FC ≥ 2).
Quantification of ChIP-seq signal in each peak.
To determine the read coverage across the whole genome for a BAM file, we used featureCounts from subread 1.5.2 56 . The data input to featureCounts consists of (a) uniformly processed BAM files and (b) a consensus peak file in simplified automation format (SAF). The consensus peak signals for H3K4me3 and H3K27ac were generated by taking the union of MACS2 narrowPeak files of cell-specific and homogenate consolidated datasets that are (i) H3K4me3 PFC neuronal, (ii) H3K4me3 PFC non-neuronal, (iii) H3K4me3 ACC neuronal, (iv) H3K4me3 ACC neuron-depleted and (v) H3K4me3 PFC HBCC homogenate and the union of MACS2 broadPeaks files of (v) H3K27ac PFC neuronal, (vi) H3K27ac PFC neuron-depleted, (vii) H3K27ac ACC neuronal, and (viii) H3K27ac ACC neuron-depleted, respectively. featureCounts quantifies the number of reads for each sample in every peak region of consensus signal. The counts were put together in a matrix separately for H3K4me3 and H3K27ac marks, with 74 (cell-specific, 63; homogenate, 11) samples from 28 individuals (cell-specific, 17; homogenate, 11) as rows for H3K4me3 and 83 (cell-specific, 66; homogenate, 17) from 34 individuals (cell-specific, 17; homogenate, 17) as rows for H3K27ac and 107,480 and 152,590 peak regions as columns for H3K4me3 and H3K27ac, respectively. This matrix was converted into log 2 counts per million (CPM) using TMM normalization 57 to correct for the total number of reads. The log 2 CPM matrix was used for downstream analysis.
Decomposing variation into multiple components with variancePartition.
For the cell-specific dataset for each histone mark, the epigenetic variance of each peak was decomposed into variation attributable to cell type, subject, brain region and sex, plus the residual variation: These four variables are categorical and so were modeled as random effects. The analysis was performed by modeling the log 2 CPM with a linear mixed model implemented in variancePartition v1.4.1 24 and treating each variable as a random effect. Each peak was considered separately and the results for all peaks were aggregated afterwards. Results were summarized in terms of the fraction of total variation explained by each variable for each peak.
A variancePartition analysis was also performed on additional metadata variables, such as QC statistics (i.e., NSC, RSC, PCR PBC and NRF) and sample processing batches (library preparation date of chip, chip DNA volume, chip DNA amount (nanograms), total chip DNA in a library, library preparation operator, library AMpure bead lot, library PCR cycles number, library volume, library sequencing batch, library sequencing submission date, library preparation library batch). Continuous variables were modeled as fixed effects and categorical variables were modeled as random effects. The percentage variation explained by technical variables such as experimental batches or QC statistics was mainly explained by the four major variables described above.
Principal component analysis.
As a QC step, we performed principal component analysis on the log 2 CPM matrix to identify outliers. Eight samples were identified as outliers ( Supplementary Table 2 ), and these corresponded to samples that barely passed our previous QC cutoffs. These samples were excluded from further analysis.
Differential histone modification.
For the cell-specific dataset for each mark, we performed differential analysis to identify peak regions with significant differences (i) across the cell types (neuronal and non-neuronal) and (ii) across brain regions (ACC neuronal and PFC neuronal, and ACC neuron-depleted and PFC neurondepleted) using edgeR v.3.14.0 58 .The CPM matrix was prefiltered to regions with CPM > 1 in at least five samples for both histone marks and normalized using the calcNormFactors function, which uses the trimmed mean of M-values (TMM) 57 . The edgeR software models the read count matrix as a negative binomial distribution using cell types and brain regions as covariates. We fit the normalized CPM matrix to a quasi-likelihood negative binomial generalized log-linear model using the glmQLFit function with robust = TRUE option. The quasi-likelihood F-test was then applied to identify peak regions that are significantly different across cell types and brain region (for both neuronal and non-neuronal cell types) using glmQLFTest (glmQLFit object, contrast = cell type or brain region). Multiple testing was done by applying the Benjamini-Hochberg method to the P values to control false discovery rate 59 . The total number of differential peaks was determined at a FDR of 5%. The coordinates of cell-specific peaks (neuronal, nonneuronal) are listed in Supplementary Table 11 and region-specific peaks (ACC, PFC) are listed in Supplementary Table 12 (ACC neuronal, PFC neuronal, ACC non-neuronal and PFC non-neuronal).
Comparison with the Roadmap Epigenomics Project. For each mark, we measured the similarity of genomic regions of cell-specific (four) and homogenate (one) consolidated datasets: ACC neuronal, PFC neuronal, PFC neuronal, PFC neuron-depleted (non-neuronal) and PFC HBCC homogenate with Roadmap Epigenomics Project (REP) data from 111 tissues. We used bedtools jaccard -a sample bed file -b REP bed file 60 . This command outputs the Jaccard index parameter (see Supplementary Table 4 ), which is evaluated as
Cell composition analysis. Cell-type proportions were quantified using R library CellMix 61 . Using our neuronal and non-neuronal ChIP-seq datasets, we generated cell-type signatures to run deconvolution on homogenate samples to quantify the proportion of each cell type for every sample. We first created the basis set for neuronal and non-neuronal cell types by taking the mean of RPKM values for each peak across neuronal samples and neuron-depleted samples, respectively, for both marks. We defined as our input matrix the HBCC homogenate samples' RPKM matrix. We then used the lsfit method from the CellMix library for decomposition of the RPKM matrix to calculate the coefficients of neuronal and non-neuronal cell types.
Genic annotation. We used CHIPSeeker v.1.8.9 62 to annotate peaks to seven distinct categories: promoter, 5′ UTR, exons, introns, 3′ UTR, downstream (≤ 3 kb) and distal intergenic regions within 5 kb downstream and upstream of the transcription start site. The transcript database used for the annotation was ENSEMBL v75 for GRCh37.70.
Correlation of ChIP-seq reads counts with RNA-seq expression. We next examined the enrichment of ChIP-seq reads counts around transcription start site (TSS) region of protein-coding genes with RNA-seq expression from 537 individuals for 20,330 genes from PFC brain regions. We use nsgplot v2.61 55 to plot ChIP-seq read enrichment of combined PFC neuronal datasets as a function of 15 kb distance upstream and downstream around the TSS for both marks. Enrichments plots were made for all protein-coding genes grouped into five categories sorted by the RPKM mean values across 537 subjects from the CommonMind RNA-seq dataset 7 .
Histone QTL enrichment analysis. The overlap between peak regions with hQTLs detected in lymphoblastoid cell lines (LCL) 25 and peak regions exceeding a variance percentage cutoff for a particular variable for both marks was computed. This overlap was then compared to the overlap computed from randomly permutated variance percentages. Each peak region was assigned a value based on the percentage of variance explained by a particular variable in the variancePartition analysis. At each of 40 cutoff values, the overlap between peak regions with values exceeding this cutoff and the peak regions with a hQTL for the same histone mark in LCLs and PFC was evaluated using the Jaccard index.
The overlap was computed for the observed data and 10,000 datasets with the variance percentages randomly permutated. At each cutoff, the enrichment is computed as
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The mean enrichment value and the 90% confidence interval are shown in the plot. Only regions on autosomes are considered, leaving 9,575 H3K4me3 hQTLs in LCLs and 1,912 H3K27ac hQTLs in postmortem PFC. Permutation and overlap calculations were performed using regioneR 63 .
We ran a similar analysis to test the overlap between the peak regions with (a) hQTLs in H3K27ac-modified peak regions from PFC homogenate from Sun et al. 10 and (b) hQTLs in H3K9ac-modified peak regions from PFC homogenate from Ng et al. 11 with peak regions from (i) H3K27ac PFC neuronal, (ii) H3K27ac PFC non-neuronal, (iii) H3K27ac ACC neuronal and (iv) H3K27ac ACC non-neuronal datasets and (v) differentially modified neuronal and (vi) non-neuronal H3K27acmodified peak regions.
The overlap observed is the Jaccard index between hQTL regions a,b and datasets i-vi. The overlap permuted is the Jaccard index between abovementioned datasets i-vi and 1,000 datasets obtained by randomly permuting x peak regions from (a) PFC homogenate from Sun et al. 10 and (b) PFC homogenate from Ng et al. 11 (x = length of hQTLs).
Pathway enrichment analysis. Genomic Regions Enrichment of Annotations
Tool (GREAT) 19 was used to interpret differentially modified peaks in terms of the biological function of nearby genes. We took the sets of peaks that showed significant (< 5% FDR) differences across cell types (neurons and non-neurons) from edgeR analysis and tested for functional enrichment using the consensus peaks for each mark as a background (see Supplementary Tables 7 and 9 ). The settings for genomic regions used were as follows: proximal, 5.0 kb upstream and 5.0 kb downstream; distal, to 100 kb. Since many of the gene sets from different databases are redundant, we only considered REACTOME, KEGG and PID pathways as our complete gene sets. Significance testing for the enrichment analysis was based on the binomial test compute by GREAT and using a Bonferroni cutoff 4.7 × 10 −5 based on these tests.
Overlap of identified peaks with disease-and trait-associated genetic variants.
To assess whether the genomic regions carrying the two assayed histone marks in the different brain regions and cell types play a role in the various traits and diseases, we examined the overlap with common genetic variants identified by genome-wide association studies (GWAS). For this, we employed LD-score partitioned heritability 20 , which estimates whether common genetic variants in the genomic regions of interest explain more of the heritability of a given trait than genetic variants not overlapping the genomic regions of interest, normalized by the number of variants in either category. The algorithm allows for correction of the general genetic context of the annotation using a baseline model of broad genomic annotations (such as coding, intronic and conserved). By using this baseline model, the algorithm focuses on enrichments above those expected from the genetic context of the interrogated regions. We applied the method to a range of GWAS traits with presumed involvement of the brain 29,64-68 and well-powered studies of traits not believed to involve the brain [69] [70] [71] . For the Alzheimer's disease GWAS, see "Materials and methods for the Alzheimer's disease GWAS" below. We used the European-only versions of the summary statistics when available. The coronary artery disease analysis was the only one remaining with a mixed ancestry (77% Europeans). We excluded the broad MHC region (chr6:25-35 MB) and otherwise used default parameters.
Allele-specific QTL analysis. We used RASQUAL 28 to call cell-and tissue-specific cis-hQTLs in our datasets-PFC neuronal, ACC neuronal, PFC non-neuronal, ACC non-neuronal and PFC tissue homogenate-for each of the two histone marks, H3K27ac and H3K4me3. RASQUAL uses allele-specific reads counts at heterozygous sites to increase power to detect cis-hQTLs correlated with quantitative variation in histone modification.
With RASQUAL, a feature in our ChIP-seq dataset is defined by a set of start and end coordinates of identified peaks for calling a cis-hQTLs. RASQUAL requires a few data preprocessing steps before calling cis-hQTLs. (i) ChIP-seq read counts and offset matrices as text and bin files for each dataset and mark. We used the bedtools --nuc option to obtain GC content for each identified peak region and used that as an input for the offset calculation from the counts matrix in the custom makeOffset.R script file. All text files were converted to bin files using the text2bin.R script. (ii) Covariate text and bin file for each dataset and mark. The confounding factors in ChIP-seq reads counts are obtained by applying PCA to log FPKMs with and without permutation and outputs the first N components whose variances are greater than those from permutation results. We used the makeCovariates.R script file and found five components as covariates for PFC neuronal, ACC neuronal, PFC non-neuronal and ACC non-neuronal datasets for H3K4me3 and H3K27ac marks whereas PFC homogenate samples had three or four components for H3K4me3 and H3K27ac, respectively. (iii) Allele-specific count VCF file. The createASVF.sh script file was used to count allele-specific reads for every individual for a given SNP within a feature. We used whole-genome sequencing data from 17 individuals to generate allele-specific counts. WGS paired-end 150-bp reads were aligned to the GRCh37 human reference using the Burrows-Wheeler Aligner (BWA-MEM v0.78) and processed using a best-practices pipeline that included marking of duplicate reads with Picard tools (v1.83; http:// broadinstitute.github.io/picard/), realignment around indels, and base recalibration via the Genome Analysis Toolkit (GATK v3.2.2). All individuals' WGS data were merged into a single vcf file and used as one of the inputs to createASVF.sh.
We ran RASQUAL feature on 90,767 H3K4me3 peaks for PFC neuronal (n = 17), ACC neuronal (n = 14), PFC non-neuronal (n = 17), ACC non-neuronal (n = 15) and PFC homogenate (n = 11) datasets and 127,773 H3K27ac peaks from PFC neuronal (n = 17), ACC neuronal (n = 17), PFC non-neuronal (n = 17), ACC non-neuronal (n = 15) and PFC homogenate (n = 17) datasets. SNPs were tested within 10 kb of the cis region from peak start and end points. We used Benjamini-Hochberg q < 0.05 as a threshold to determine the significant cis-hQTLs.
hQTL-GWAS overlap.
To test the overlap of significant hQTLs (RASQUAL q < 0.05) with GWAS identified schizophrenia loci, we took the list of lead SNPs and SNPs in LD (R 2 > 0.8) with the latter. The list was downloaded from https:// www.med.unc.edu/pgc/results-and-downloads/downloads. We report the overlapping loci separately with cell-specific hQTLs-PFC NeuN + , PFC NeuN -, ACC NeuN + , ACC NeuN --and PFC HBCC tissue homogenate. hQTLs for both marks are listed in Supplementary Table 10 72 .
Materials and methods for the Alzheimer's disease GWAS. Summary statistics for Alzheimer's disease were provided by the International Genomics of Alzheimer's Project (IGAP). IGAP is a large, two-stage study based on genomewide association studies (GWAS) on individuals of European ancestry. In stage 1, IGAP used genotyped and imputed data on 7,055,881 single-nucleotide polymorphisms (SNPs) to meta-analyze four previously published GWAS datasets consisting of 17,008 Alzheimer's disease cases and 37,154 controls (the European Alzheimer's Disease Initiative (EADI), the Alzheimer Disease Genetics Consortium (ADGC), the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium (CHARGE) and the Genetic and Environmental Risk in AD consortium (GERAD)). In stage 2, 11,632 SNPs were genotyped and tested for association in an independent set of 8,572 Alzheimer's disease cases and 11,312 controls. Finally, a meta-analysis was performed combining results from stages 1 and 2.
Statistical parameters
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The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code Data collection Postmortem brain tissue was provided by the HBCC at the National Institute of Mental Health, tissue is available to investigators compliant with NIH and HBCC rules and regulations . Antibodies and all other reagents were commercially available. Data analysis R, bedtools, samtools, ngsplot, picard, macs2, SPP, PeakSeq, variancePartition, GREAT, ChIPSeeker v.1.8.9
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). 
Validation
Specificity was checked with histone H3 peptide array (Cat# 16-667; Millipore).Anti-NeuN-Alexa488 (Cat# MAB377X, EMD Millipore) antibody to stain nuclei, specificity was checked by microscopy.
ChIP-seq
Data deposition
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Confirm that you have deposited or provided access to graph files (e.g. BED files) for the called peaks.
Data access links
May remain private before publication.
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Files in database submission 1) BAM and BED with metadata files, 2) counts per million matrix of all individuals and list of significant peaks from differential modification analysis Genome browser session (e.g. UCSC) no longer applicable Methodology Replicates not applicable, postmortem brain
Sequencing depth
We have used paired end reads, where length of the each read is 100 bp for cell type data and 75 bp for homogenate data. Table S2 lists the number of uniquely mapped reads. Antibodies antihistone antibodies: anti-H3K4me3 (Cat# 9751BC, lot 7; Cell Signaling, Danvers, MA) and anti-H3K27ac (Cat# 39133, Lot# 31814008; Active Motif, Carlsbad, CA). 
Peak calling parameters
